Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrous carbonate (FeCO3) is an inorganic iron salt primarily utilized as a nutritional supplement and industrial chemical. In clinical practice, it serves as an oral iron source for the treatment of iron deficiency anemia, often co-administered with ascorbic acid (Vitamin C) to enhance gastrointestinal absorption. Beyond human medicine, it is widely authorized as a mineral feed additive (E1) for livestock, particularly for adult animals. Industrially, ferrous carbonate is employed in wastewater management to sequester sulfides and phosphates, as a corrosion product (siderite) in steel pipelines, and as a precursor in the development of anode materials for high-capacity lithium-ion batteries. It also occurs naturally as the mineral siderite in geological formations and ancient soils.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous carbonate.